Enteric fever is the commonest public health problem in developing countries like Nepal. Multi Drug Resistant Salmonella isolates are in vitro suscepti ble to Quinolone but exhibited a higher Minimum Inhibitory Concentrati on in vivo. Such phenomenon can be demonstrated by simple disc diff usion test of Nalidixic Acid which shows resistance. This study is conducted to determine prevalence of Nalidixic Acid Resistant Salmonella with their anti bioti c sensiti vity patt ern at Shree Birendra Hospital, Chauni, kathmandu.
INTRODUCTION
Enteric fever (Typhiod fever and Paratyphoid fever) remains an important public health in developing countries. In the recent study, it was esti mated that over 2.16 million episodes of typhoid occurred worldwide, resulti ng in 216000 deaths and that more than 90% of this morbidity and mortality in Asia. 2 Since the isolati on of multi drug-resistant(MDR) strains which show resistance to all fi rst-line anti bioti cs(chloramphenicol, ampicillin and trimethoprimsulfamethoxazole) in late 1980s, the fl uoroquinolone class of anti bioti cs has beome the treatment of choice for enteric fever 3, 4 . Fluoroquinolones have good in vitro and clinical acti vity against Salmonella species and are oft en treatment of choice in cases of life-threatening Salmonellosis due to multi -drug resistant strains 5 .
In the recent years, several treatment failures with fl uoroquinolones have also been reported due to decreased suscepti bility to Ciprofl oxacin 6, 7 . Such isolates appear suscepti bility with routi ne disc diff usion tests. Therefore, routi ne applicati on of these tests for such strains is not convenient and the literature suggests the resistance to Nalidixic Acid may be an indicator of decreased susceptibility to Ciprofl oxacin 6, 8, 9, 10 .
Enteric fever caused by Nalidixic Acid resistant (NAR) isolates in endemic zone is associated with higher rate of morbidity and mortality parti cularly prolonged fever clearance ti me and increased need for retreatment of fever pati ents 8 .
Therefore, this study was conducted retrospecti vely to fi nd out the prevalence of the Nalidixic Acid resistant Salmonella at Shree Birendra Hospital, Chauni.
METHOD
This study was conducted at Shree Birendra Hospital, from January 2011 to August 2011. Total of 3945 blood sample were collected from the pati ents suspected of enteric fever. About fi ve milliliter of blood was collected asepti cally and was mixed with Brain Heart Infusion. It was then processed according to standard methodology 11 . Serotyping of S.enterica was done using polyvalent O-anti sera A-G and individual O and H-anti sera (Denka Seiken, Japan).
Anti microbial suscepti bility tests for S.typhi and S.paratyphi A were performed by Kirby-Bauer disk diff usion method following clinical and laboratory standard insti tute (CLSI) guideline 12 . Anti bioti cs used for suscepti bility were Amoxicillin, Azithromycin, Co-trimoxazole, Chloramphenicol, Cefotaxime, Ciprofl oxacin, Ofl oxacin and Nalidixic Acid.
RESULTS
A total of 3945 blood samples of suspected case of enteric fever were collected. Out of these only 280 (7.09%) samples showed positi ve for bacterial growth. Among the growth positi ve cases, 114 (40.7%) were S.enterica serotype Typhi and remaining 166 (59.2%) were S.enterica serotype Paratyphi A. 221(78.92%) were NARS isolates which included both S.typhi and S.paratyphi A. Fift y four percent of S.typhi and 95.78% S.paratyphi A were NARS.
DISCUSSION
The main causes of resistance to quinolones in Gram-negati ve bacteria are mutati on in the genes coding for DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE) 13 . Target protecti on mediated by the Qnr protein and decreased accumulati on of anti bioti c due to a lower outer membrane permeability has also been considered as mechanism of resistance 14 . Giraud et.al postulated that the enhanced acti ve effl ux and early overproducti on of the AcrApump in isolates with the gyrA mutati on could be responsible for the decreased in suscepti bility to fl uoroquinolone 15 . It has been suggested that a low level of resistance to ciprofl oxacin, probably due to point mutati on in the gyrA gene, may not be detected by in vitro suscepti bility tests using the current MIC breakpoints for ciprofl oxacin. Therefore, in vitro resistance to Nalidixic Acid can be used to detect this low level resistance 16 .
The prolonged defervescence or treatment failure in typhoid fever associated with ciprofl oxacin, ofl oxacin or other fl uoroquinolone therapy have been reported from many countries 17 . It has been noted that NARS strains were found to have treatment failure rate upto 36% and prolonged fecal carriage when treated with Ofl oxacin 18 .
The present study showed total of 78.92% NARS strain which was in accordance to study done by Khanal B et.al 19 Nepal is endemic zone for enteric fever and having a series of epidemic over the last decades with changing resistance patt ern. The fi rst report of MDR S.enterica serotype Typhi in Nepal was published in 1991. In the following years, with the introducti on of fl uoroquinolones in the treatment, Nalidixic-Acid resistant strains associated with reduced suscepti bility to Fluoroquinolones have been conti nuously reported from Nepal and trend of resistance is increasing 22 . Present study also showed that patt ern of resistance is changing even in the same region.
CONCLUSION
Sensiti vity patt ern of the Salmonella isolates are ever changing. Nowadays fl uoroquinolone group of drugs have been used as empiric therapy for the enteric fever at the sameti me reduced level of resistance to fl uoroquinolone is as emerging problem. Fortunately, which can be detected simply by Nalidixic Acid disc diff usion method. Therefore, screening for such strains by Nalidixic Acid disc diff usion must be incorporated in routi ne laboratory procedure. This will help for early diagnosis of low level resistance to fl uoroquinolone so as to think for another therapeuti c opti ons.
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